| Title | Category   |
|
|---|---|---|
| add to favorites | See High School Graduation Rates By State | Cars |
| See High School Graduation Rates By State THE NATIONAL HIGH school graduation rate sits at 84.6%, with average state graduation rates for 2016-2017 ranging from 72% to 94%, according to data reported by 16,404 ranked schools in the 2019 U.S. News Best High Schools rankings.International high school As the national high school graduation rate continues to rise – up 0.5 percentage points over the prior year per data from the National Center for Education Statistics – disparities persist as the graduation rates for Asian and Pacific Islanders and white students continue to outpace the graduation rates of Hispanic, black, Native American and Alaska Native students, according to NCES. Likewise, graduation rates among students with disabilities and economically disadvantaged students are on the rise, while the graduation rate for students with limited English proficiency fell 0.4 percentage points over the prior year. The map below shows the average graduation rate for each state. Arizona and New Mexico have the lowest average graduation rates at 72%, while Iowa, Kentucky and Nebraska have the highest at 94%. U.S. News collected graduation rates for the Best High Schools rankings from officials in each state. The rates correspond to the 2017 graduation cohort, which is made up of students who entered ninth grade in the 2013-2014 school year.The number of schools that reported graduation rate data in each state ranges from 30 in the District of Columbia to 1,578 in California. While no state had a 100% average graduation rate, some individual schools reached 100% for the class of 2017. Texas has the highest number of schools with a 100% graduation rate by a large margin – 269 schools – followed by North Carolina with 67 schools. There are seven states where no high schools graduated 100% of students, according to the data collected for the 2019 rankings. | ||
| add to favorites | Special show for CIIE exhibits | Cars |
| Special show for CIIE exhibits A batch of exhibits at the China International Import Expo will be brought into the Hongqiao Import Commodity Exhibition and Trading Center.The second China International Import Expo will be held at the National Exhibition and Convention Center in Shanghai from November 5 to 10, 2019.For further information about China International Import Expo, please visit: https://www.shine.cn/China-International-Import-Expo/ or https://www.shine.cn/ciie2019/v1.To get more ciie china 2019, you can visit shine news official website. Among them are vintage cars from US car dealer Bund on the Boulevard LLC which have become star exhibits at the event. After the expo, Hall 1 of the center will become an exhibition area especially for the imported autos.To date, the center, a major platform offering exhibition and trading services to support the CIIE, has attracted nearly 80 exhibitors, of which nearly 30 are taking an active part in the import expo. Fu Naixun, deputy director of Hongqiao Central Business District's administrative committee, said the center will serve as an important platform supporting the Hongqiao CBD's development of an international trading center. Many CIIE exhibits will be brought there, allowing the public to take a close look or experience and buy the products, Fu said.Zhao Jun, director of the committee's commerce office, issued a series of support policies and measures. For instance, public transport will be adjusted, making it become more convenient for visitors to reach the center. Zhao hopes Hongqiao CBD will be the first stop for people to visit in China and the center will be a foothold for foreign enterprises to expand their business in the Chinese market. At the CIIE, a massive bluefin tuna from the Mediterranean brought by Spanish company Albo was filleted on site, attracting dozens of people to watch and taste. Customers can buy such tuna at the Hongqiao ICETC, as Liancheng Overseas Fishery (Shenzhen) Co, a leading fishery company focusing on long-line fresh tuna fishing in the middle and west Pacific Ocean, has made agreements with the center to offer more high-quality imported seafood for Chinese consumers. | ||
| add to favorites | Technology boom in health care | Cars |
| Technology boom in health care Artificial Intelligence, blockchain and robotic technologies are booming in the health care industry, given market demand and consumer expectations, Shanghai Daily learned during the ongoing China International Import Expo. The second China International Import Expo will be held at the National Exhibition and Convention Center in Shanghai from November 5 to 10, 2019.For further information about China International Import Expo, please visit: https://www.shine.cn/China-International-Import-Expo/ or https://www.shine.cn/ciie2019/v1.To get more ciie china 2019, you can visit shine news official website. AI-featured devices and data management against diabetes, a prototype device to improve sleep quality and the world’s smallest pacemaker are showcased in Hall 7.1 at the National Exhibition and Convention Center.A SmartSleep Deep Sleep Headband, a Philips prototype, interested visitors who included an electronics retailer and hospital representatives. With a sensor, Phillips can collect and analyze users' sleep data before sending out “waves” to improve the quality of their sleep. The product is expected to debut in China next year. Ping An Smart Healthcare and Sanofi reached cooperation to fight against diabetes based on AI and a data management system at the expo. In China, there are more than 114 million diabetes patients, over 11 percent of the population. Big data management is used to track and better serve patients while blockchain technologies are used to protect privacy and data, according to Ping An Smart Healthcare. Meanwhile, Medtronic released capsule-sized pacemaker Micra, the world’s smallest pacemaker. It’s 93 percent smaller than conventional pacemakers with an estimated average battery life of 12 years. | ||
| add to favorites | Hydrochlorothiazide Tablets Recalled at Consumer Level | Cars |
| Hydrochlorothiazide Tablets Recalled at Consumer Level Accord Healthcare Inc. is voluntarily recalling 1 lot of Hydrochlorothiazide Tablets USP, 12.5 mg, at the consumer level, due to a potential labeling mix-up. According to the company, the lot (PW05264) of 100-count bottles of Hydrochlorothiazide Tablets USP 12.5 mg has been found to contain 100 Spironolactone Tablets USP 25 mg.wisepoqder β-agonist Powder Accord was made aware of the issue with Lot PW05264 through a product complaint reported from a pharmacy. Based on findings of both preliminary and interim investigations carried out at the manufacturing site, company officials said, in a press release, that it believes no other lots of Hydrochlorothiazide Tablets are involved in this mix-up. Hydrochlorothiazide tablets are indicated in the management of hypertension, either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of the condition. Spironolactone tablets are indicated in the management of primary hyperaldosteronism, edematous conditions for patients with congestive heart failure, cirrhosis of the liver accompanied by edema and/or ascites, nephrotic syndrome, essential hypertension, hypokalemia, severe heart failure. Use of spironolactone tablets instead of hydrochlorothiazide tablets, poses the risk of contracting increased potassium levels in certain individuals, resulting in adverse events that range from limited health consequences to life-threatening situations in certain individuals. To date, Accord has not received any reports of adverse events related to the recall of Lot PW05264. Accord's Hydrochlorothiazide Tablets USP 12.5 mg are light orange to peach colored, round, biconvex tablets debossed with H on one side and 1 on another side. The company is encouraging consumers in possession of Accord Hydrochlorothiazide that does not match the description, or who are unsure, to return with it to their pharmacy or consult a health care provider for confirmation. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program. | ||
| add to favorites | Intermittent furosemide during acute HFpEF favors kidneys | Cars |
| Intermittent furosemide during acute HFpEF favors kidneys Patients with heart failure with preserved ejection fraction who were hospitalized for acute decompensation had a significantly smaller rise in serum creatinine when treated with intermittent, bolus doses of furosemide, compared with patients who received a continuous furosemide infusion in a single-center, randomized trial with 90 patients. Intermittent furosemide also resulted in many fewer episodes of worsening renal function. In the trial, 12% of patients who received bolus furosemide doses developed worsening renal function during hospitalization compared with 36% of patients treated with a continuous furosemide infusion, Kavita Sharma, MD, said at the annual scientific meeting of the Heart Failure Society of America.wisepoqder Furosemide While acknowledging that this finding is preliminary because it was made in a relatively small, single-center study, “I’d be cautious about continuous infusion” in acute decompensated patients with heart failure with preserved ejection fraction (HFpEF); “bolus is preferred,” Dr. Sharma said in a video interview.Results from the prior Diuretic Optimization Strategies Evaluation (DOSE) trial, published in 2011, had shown no significant difference in renal function in hospitalized heart failure patients randomized to receive either bolus or continuous furosemide, but that study largely enrolled patients with heart failure with reduced ejection fraction (HFrEF) (N Engl J Med. 2011 Mar 3;364[9]:797-805). “When patients with HFpEF are hospitalized with acute heart failure there is a high rate of kidney injury, that often results in slowing diuresis leading to longer hospital stays. With adjustment for changes in blood pressure and volume of diuresis we saw a fourfold increase in worsening renal failure [with continuous infusion], so you should think twice before using continuous dosing,” said Dr. Sharma, a heart failure cardiologist at Johns Hopkins Medicine in Baltimore. She presented results from Diuretics and Dopamine in Heart Failure With Preserved Ejection Fraction (ROPA-DOP), which randomized 90 hospitalized heart failure patients with a left ventricular ejection fraction of at least 50% and an estimated glomerular filtration rate of more than 15 mL/min/1.73 m2. The enrolled patients averaged 66 years old, 61% were women, their average body mass index was 41 kg/m2, and their average estimated glomerular filtration rate was 58 mL/min/1.73 m2. The study’s primary endpoint was percent change in creatinine during hospitalization, which rose by an average 5% in the patients who received intermittent bolus furosemide and by an average 16% in patient who received a continuous infusion, a statistically significant difference. In a regression analysis that controlled for between-group differences in patient’s age, sex, race, body mass index, smoking status, changes in systolic blood pressure, heart rate, fluid balance after 72 hours, and other variables, patients treated with continuous furosemide infusion averaged an 11% greater increase in serum creatinine, Dr. Sharma reported. After similar adjustments, the secondary endpoint rate of worsening renal function was more than four times more likely to occur in the patients on continuous infusion compared with those who received intermittent bolus treatment, she said. A second aspect of the ROPA-DOP trial randomized the same patients to received either low dose (3 mcg/kg per min) dopamine or placebo during hospitalization. The results showed that low-dose dopamine had no significant impact on either change in creatinine levels or on the incidence of worsening renal function compared with placebo, though dopamine treatment did link with a nonsignificant trend toward somewhat greater diuresis. These results were consistent with prior findings in the Renal Optimization Strategies Evaluation (ROSE) trial (JAMA. 2013 Nov 18;310[23]:2533-43), which used a mixed population of patients with HFpEF or HFrEF but predominantly patients with HFrEF, Dr. Sharma noted. | ||
| add to favorites | As-needed budesonide-formoterol bests albuterol for exacerbation prevention in mild asthma | Cars |
| As-needed budesonide-formoterol bests albuterol for exacerbation prevention in mild asthma Single combination inhaler treatment with budesonide-formoterol on an as-needed basis, compared with albuterol, more than halved the risk for severe asthma attacks in patients with mild asthma, according to the results of the Novel START trial presented at the American Thoracic Society International Conference.wisepoqder Formoterol “We undertook a real-world study and the question we wanted to ask was that in adults with intermittent and mild asthma who were treated with reliever therapy alone — step 1 treatment — what is the efficacy of a combination inhaled corticosteroid and fast-onset long-acting beta-agonist inhaler used as a reliever alone with two other therapeutic regimens. The first was a continuation of step 1 therapy with reliever therapy alone and the other was a step up to step 2 therapy with maintenance inhaled corticosteroids and reliever therapy, as recommended by asthma guidelines,” Richard Beasley, DSc, from the Medical Research Institute of New Zealand and the Capital and Coast District Health Board, said during his presentation of the data. The 52-week, open-label, randomized, parallel-group, controlled trial included 668 patients with mild asthma who were randomly assigned one of three treatments: two inhalations of albuterol 100 µg (Ventolin, GlaxoSmithKline) from a pressurized metered-dose inhaler as needed for asthma symptoms; one inhalation of budesonide 200 μg (Pulmicort Turbuhaler, AstraZeneca) taken twice daily plus as-needed albuterol; or one inhalation of budesonide 200 μg/formoterol 6 μg (Symbicort Turbuhaler, AstraZeneca) as needed. Of 675 patients enrolled from 2016 to 2017 in New Zealand, Australia, United Kingdom and Italy, 668 were included in the analysis. To qualify for inclusion, patients had to be 18 to 75 years of age; a short-acting beta agonist (SABA) had to be the sole asthma therapy in the previous 3 months; and they had to report use of the SABA on at least two occasions in the last 4 weeks, but on average no more than two occasions per day, in the previous 4 weeks. The primary outcome was annualized asthma exacerbation rates per patient. Exacerbations were characterized as worsening asthma that led to urgent medical care consultation, a prescription for systemic glucocorticoids or an episode of high beta-2-agonist use, which was defined as use of albuterol more than 16 times or the use of budesonide-formoterol more than eight times during 24 hours. | ||
| add to favorites | Formoterol for COPD | Cars |
| Formoterol for COPD Formoterol (brand names Perforomist, Foradil) is a bronchodilator in a class of medications called long-acting beta agonists (LABAs). It is used to control wheezing, shortness of breath, coughing and chest tightness in people with COPD. Formoterol is not intended to treat asthma and can cause severe risks to asthma patients. It works for COPD patients by relaxing and opening the airways to the lungs, making it easier to breathe.wisepoqder Formoterol powder How does formoterol for COPD work? Formoterol is a long-acting beta2-adrenergic receptor agonist (beta2-agonist) that works in the lungs as a bronchodilator. Its action has a rapid onset and its effects are maintained for at least 12 hours. It becomes effective after binding to correspondent receptors, called beta-adrenoceptors, and activating them by stimulating the adenyl cyclase, an enzyme found inside the cells of the lung muscles and is involved in the synthesis of cyclic adenosine monophosphate (cAMP). When cAMP levels are elevated, the muscle cells of the airways become relaxed, leading to bronchodilation. There are three types of beta-adrenoceptors in three different types of cells: the muscle cells of the airways, the heart, and the adipose (fat) tissue cells. This means that formoterol may have functions in other cells, but its precise function is not known. Studies of formoterol The effectiveness of formoterol in the treatment of COPD has been shown in various clinical studies, whether as a pressurized metered dose inhaler or a dry powder inhaler.Most studies show that formoterol has proven efficacy, safety, and tolerability profiles in people with COPD. The National Heart, Lung and Blood Institute and the World Health Organization collaborated on the Global Initiative for COPD – GOLD, and according to this initiative, long-acting bronchodilators are of primary importance to manage COPD symptoms, are used on an as-need or regular basis to reduce or prevent symptoms, and are convenient and effective. Most studies evaluating formoterol for the treatment of COPD attribute its success to its rapid action and selective activity toward the beta2-adrenergic receptors. Formoterol can work as rapidly as five minutes, and its effects are maintained for up to 12 hours. Studies have also shown that formoterol controls symptoms better than ipratropium and is more effective than theophylline in reducing exacerbations and increasing the number of days without rescue medication, and with a better tolerance. | ||
| add to favorites | Ethacrynic Acid | Cars |
| Ethacrynic Acid Why is this medication prescribed? Ethacrynic acid is used to treat edema (fluid retention; excess fluid held in body tissues) in adults and children caused by medical problems such as cancer, heart, kidney, or liver disease. Ethacrynic acid is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine.wisepoqder Ethacrynic acid How should this medicine be used? Ethacrynic acid comes as a tablet to take by mouth. It is usually taken once or twice a day with food or after meals depending on your doctor's instructions. Take ethacrynic acid at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take ethacrynic acid exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Other uses for this medicine Ethacrynic acid is also used to treat high blood pressure and a certain type of diabetes insipidus that does not respond to other medicines. Talk to your doctor about the possible risks of using this medicine for your condition.This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information. What special precautions should I follow? Before taking ethacrynic acid, tell your doctor and pharmacist if you are allergic to ethacrynic acid, any other medications, or any of the ingredients in ethacrynic acid tablets. Ask your doctor or pharmacist for a list of the ingredients. tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements and herbal products you are taking or plan to take. Be sure to mention any of the following: aminoglycoside antibiotics such as amikacin and gentamicin (Garamycin); anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); cephalosporin antibiotics such as cefaclor, cefadroxil, and cephalexin (Keflex); corticosteroids such as dexamethasone, hydrocortisone (Cortef), methylprednisolone (Medrol), prednisolone (Prelone), or prednisone (Rayos); digoxin (Lanoxin), lithium (Lithobid); and nonsteroidal anti-inflammatory medications such as ibuprofen (Advil, Motrin) and naproxen (Aleve). Your doctor may need to change the doses of your medications or monitor you more carefully for side effects. tell your doctor if you have kidney disease. Your doctor may tell you not to take ethacrynic acid. tell your doctor if you have or have ever had diabetes, gout, or liver disease. tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking ethacrynic acid, call your doctor. talk to your doctor about the risks and benefits of taking ethacrynic acid if you are 65 years of age or older. Older adults should not usually take ethacrynic acid because it is not as safe as other medications that can be used to treat the same condition. | ||
| add to favorites | Indications and Usage for Esmolol Injection | Cars |
| Indications and Usage for Esmolol Injection Esmolol Hydrochloride in Sodium Chloride Injection is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. Esmolol Hydrochloride in Sodium Chloride Injection is also indicated in noncompensatory sinus tachycardia where, in the physician's judgment, the rapid heart rate requires specific intervention. Esmolol Hydrochloride in Sodium Chloride Injection is intended for short-term use.wisepoqder Esmolol Intraoperative and Postoperative Tachycardia and Hypertension Esmolol Hydrochloride in Sodium Chloride Injection is indicated for the short-term treatment of tachycardia and hypertension that occur during induction and tracheal intubation, during surgery, on emergence from anesthesia and in the postoperative period, when in the physician's judgment such specific intervention is considered indicated. Esmolol hydrochloride in sodium chloride injection is administered by continuous intravenous infusion with or without a loading dose. Additional loading doses and/or titration of the maintenance infusion (step-wise dosing) may be necessary based on desired ventricular response. In the absence of loading doses, continuous infusion of a single concentration of esmolol reaches pharmacokinetic and pharmacodynamic steady-state in about 30 minutes. The effective maintenance dose for continuous and step-wise dosing is 50 to 200 mcg per kg per minute, although doses as low as 25 mcg per kg per minute have been adequate. Dosages greater than 200 mcg per kg per minute provide little added heart-rate lowering effect, and the rate of adverse reactions increases. After patients achieve adequate control of the heart rate and a stable clinical status, transition to alternative antiarrhythmic drugs may be accomplished. When transitioning from esmolol hydrochloride in sodium chloride injection to alternative drugs, the physician should carefully consider the labeling instructions of the alternative drug selected and reduce the dosage of esmolol hydrochloride in sodium chloride injection as follows: Thirty minutes following the first dose of the alternative drug, reduce the esmolol hydrochloride in sodium chloride injection infusion rate by one-half (50%). After administration of the second dose of the alternative drug, monitor the patient's response, and, if satisfactory control is maintained for the first hour, discontinue the esmolol hydrochloride in sodium chloride injection infusion. Directions for Use Esmolol hydrochloride in sodium chloride injection is available as a ready-to-infuse premixed solution in a single-dose flexible container bag. Esmolol hydrochloride in sodium chloride injection is not compatible with Sodium Bicarbonate (5%) solution (limited stability) or furosemide (precipitation). Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. | ||
| add to favorites | Dose-dependent effects of esmolol-epinephrine combination therapy in myocardial ischemia | Cars |
| Dose-dependent effects of esmolol-epinephrine combination therapy in myocardial ischemia Epinephrine has been included in resuscitation guidelines worldwide since the 1960s. It is believed that epinephrine increases the chance of restoring a person's heartbeat and improves long-term neurological outcome through increasing coronary and cerebral perfusion pressure. However, recent studies have raised doubts about the benefit of epinephrine regarding neurological outcomes in cardiac arrest. Moreover, epinephrine use in the stabilization of a cardiogenic shock in post-myocardial infarction patients has been found to increase the incidence of refractory shock. In fact, beta-adrenergic receptor stimulation has been suggested to have deleterious effects as stimulation of this pathway increases oxygen consumption and reduces sub-endocardial perfusion. In contrast, esmolol, a cardio-selective β1-blocker, has been shown to provide cardioprotection after myocardial ischemia in animal and human studies. Therefore, esmolol co-administration with epinephrine may help to reduce epinephrine-reperfusion injury but maintain esmolol-cardioprotection and epinephrine mediated increases in chronotropy and inotropy. Indeed, recent studies in animals have uncovered beneficial effects of epinephrine and esmolol co-administration in a cardiac arrest model. Based on these findings, Dr. Tobias Eckle and his team at the University of Colorado School of Medicine, University of Colorado have investigated esmolol-epinephrine combination therapy in a mouse model of myocardial ischemia and reperfusion injury.wisepoqder β-agonist Powder Comparing different esmolol doses in combination with epinephrine in a mouse model of myocardial infarction, Eckle's team demonstrated that at a specific esmolol-epinephrine ratio (15:1), esmolol-cardioprotection and epinephrine β1 mediated hemodynamic activity can both simultaneously exist during myocardial ischemia and reperfusion injury. "These findings might have implications for current clinical practice in the treatment of patients with cardiogenic shock or cardiac arrest", says Eckle. "In fact, a cardiogenic shock after myocardial ischemia disallows the use of esmolol due to hemodynamic instability." Interestingly, a definite recommendation for a specific catecholamine regimen in cardiogenic shock is lacking. Combination therapy of epinephrine with esmolol seems less intuitive in cardiogenic shock after myocardial ischemia according to the research; higher esmolol doses could compromise epinephrine mediated increases of cardiac output via β1 adrenergic receptor inotropic and chronotropic effects, or higher epinephrine doses could compromise esmolol mediated cardioprotection via β1 adrenergic receptor blockade. Surprisingly, by increasing the esmolol dose, the study team was able to restore esmolol-cardioprotection while heart rate and some blood pressures in the early reperfusion phase were significantly increased compared to an esmolol treatment alone. "This finding is novel and highlights that esmolol cardioprotection is not fully understood," says Eckle. Having increased heart rates, which is β1 mediated, and at the same time seeing cardioprotection via esmolol β1 blockade, indicates that only a part or short-term blockade of β1 receptors is necessary for the salutary effects of esmolol in myocardial ischemia and reperfusion injury. While some clinicians occasionally use esmolol in patients on epinephrine infusion due to cardiogenic shock going off cardiac bypass to treat epinephrine-induced arrhythmias, no study to date has evaluated potential cardioprotective effects of esmolol-epinephrine co-administration during cardiac bypass surgery or a cardiogenic shock. As this is the first animal study on epinephrine-esmolol co-administration during myocardial ischemia and reperfusion injury, further studies in larger animals using multiple dosing protocols are suggested. | ||
| add to favorites | Bisoprolol Market 2019 | Cars |
| Bisoprolol Market 2019 Global “Bisoprolol Market” report provides an in-depth analysis of market trends, market share, industry size, growth, opportunities. Bisoprolol market reports analyses the market by different segments, companies, regions and countries over the forecast period 2019 to 2023. The Bisoprolol Market report presents the company profile, product specifications, capacity, production value, Contact Information of manufacturer and Bisoprolol Market shares for each company. Additionally, the Bisoprolol market report explores the international and Chinese major market players in detail.wisepoqder Bisoprolol The Bisoprolol Market report delivers a basic overview of the industry including its definition, applications and manufacturing technology. Also, the Bisoprolol Industry report explores the international and Chinese Major Market players in detail. Through the statistical analysis, the Bisoprolol Market report depicts the global and Chinese total market of Bisoprolol Industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. | ||
| add to favorites | Bisoprolol Market Size, Share 2019 Regional Trend | Cars |
| Bisoprolol Market Size, Share 2019 Regional Trend Bisoprolol is a medication most commonly used for heart diseases. This specifically includes high blood pressure, chest pain from not enough blood flow to the heart, and heart failure. It is taken by mouth.In 2019, the market size of Bisoprolol is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Bisoprolol.wisepoqder Bisoprolol powder Global Bisoprolol Market 2019 Industry research report is a proficient and in-depth research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific). It covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key Vendors operating in this Global market.This Report Focuses on the Major Drivers, Restraints, Opportunities and Threats for Key Players. It also Provides Granular Analysis of Market Share, Segmentation, Revenue Forecasts and Regional Analysis till 2025. Bisoprolol is a medication most commonly used for heart diseases. This specifically includes high blood pressure, chest pain from not enough blood flow to the heart, and heart failure. It is taken by mouth.In 2019, the market size of Bisoprolol is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Bisoprolol. Global Bisoprolol market 2019 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Bisoprolol market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. Global Bisoprolol Industry 2019 Market Research Report is spread across 117pages and provides exclusive vital statistics, data, information, trends and competitive landscape details in this niche sector. | ||
| add to favorites | Furosemide and Bumetanide Use and Clinical Outcomes in Extremely Low Birth Weight Infants | Cars |
| Furosemide and Bumetanide Use and Clinical Outcomes in Extremely Low Birth Weight Infants Purpose: Extremely low birth weight (ELBW, < 1000g) infants are at risk for prolonged assisted ventilation, elevating risk for lung injury, bronchopulmonary dysplasia (BPD) and death. Furosemide and bumetanide are diuretics used to reduce respiratory support. Use of diuretics in ELBW infants is off-label; safety and efficacy is unknown. The objective of this study is to compare the incidence of clinical outcomes in ELBW infants at 2 neonatal intensive care units (NICUs) with different furosemide and bumetanide prescribing practices. Methods: Data were collected from all ELBW infants born 32 weeks without major anomalies and admitted 7 postnatal days to 2 NICUs from 2007-2012. The incidence of death, BPD, bilateral hearing aids, nephrocalcinosis/nephrolithiasis, and neurodevelopmental impairment (NDI) before 30 months of age were compared between the 2 NICUs. BPD was defined as requiring >21% oxygen, positive pressure ventilation, or continuous positive pressure at 36 weeks postmenstrual age.wisepoqder Bumetanide powder NDI was defined as scoring < 70 on the Mental or Psychomotor Development Indices, or < 85 on the Cognitive Area Composite Score on the Bayley Scales of Infant Development; having severe impairment that precluded developmental testing; or having cerebral palsy. Fisher’s exact test, chi-square test, and the Mann-Whitney U test were used to compare data where appropriate. Results: Among 765 ELBW infants, the median gestational age and birth weight were 25 weeks (range: 23-32) and 740 g (280-997), and were similar between sites (Table). Median duration of treatment and combined doses at site 1 were 7-fold and 19-fold greater than site 2, respectively. Site 1 had a lower incidence of BPD and death/BPD, but had a higher incidence of nephrocalcinosis/nephrolithiasis and bilateral hearing aids. There was no difference in the incidence of NDI. Conclusions: Diuretics use and dosing between the 2 sites differed significantly. The site with higher use had a lower incidence of BPD and death/BPD, but higher incidence of nephrocalcinosis/nephrolithiasis and bilateral hearing aids compared to the site with lower use. However, the need for bilateral hearing aids was rare (1%), and screening for nephrocalcinosis/nephrolithiasis was not performed systematically at either site. The incidence of death and NDI were similar between the 2 sites. Given the frequency of use and lack of prospective data, the safety and efficacy of diuretics in ELBW infants should be evaluated in a prospective, randomized trial. | ||
| add to favorites | Bumetanide powder Tablet | Cars |
| Bumetanide powder Tablet BUMETANIDE is a diuretic. It helps you make more urine and to lose salt and excess water from your body. This medicine is used to treat high blood pressure, and edema or swelling from heart, kidney, or liver disease. The lowest GoodRx price for the most common version of bumetanide is around $14.66, 58% off the average retail price of $35.43. Bumetanide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. Bumetanide is a "water pill" (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt.wisepoqder β-agonist Powder How to use Bumex Tablet Take this medication by mouth as directed by your doctor, usually once or twice daily. It is best to avoid taking this medication within 4 hours of your bedtime to prevent having to get up to urinate. Dosage is based on your medical condition and response to treatment. Older adults usually start with a lower dose to decrease the risk of side effects. Do not increase your dose or take it more often than directed. Take this medication regularly to get the most benefit from it. To help you remember, take it at the same time(s) of the day as directed. It is important to continue taking this medication even if you feel well. Most people with high blood pressure do not feel sick. Tell your doctor if your condition does not improve or if it worsens. If you are taking this medication to control high blood pressure, tell your doctor if your blood pressure readings remain high or increase. | ||
| add to favorites | What is Carteolol? | Cars |
| What is Carteolol? Carteolol is used alone or together with other medicines to treat increased pressure in the eye that is caused by open-angle glaucoma or a condition called intraocular (in the eye) hypertension. This medicine is a beta-blocker .wisepoqder Carteolol powder The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so. The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered: Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. Appropriate studies have not been performed on the relationship of age to the effects of carteolol in the pediatric population. Safety and efficacy have not been established . No information is available on the relationship of age to the effects of carteolol in geriatric patients. However, elderly patients are more likely to have age-related heart problems, which may require caution in patients receiving carteolol . Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive. Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. | ||
| add to favorites | Revlon to open a free beauty salon in Fitzrovia | Cars |
| Revlon to open a free beauty salon in Fitzrovia Next week, for 24 hours only, Revlon is opening a beauty salon in Fitzrovia that will offer foundation matching, blow dries, manicures and pedicures and speedy makeovers; and all completely free of charge.bikin wajah putih The 24-hour beauty salon, which will open from 7am on Thursday September 19 until 7am on Friday September 20, is to celebrate the brand’s best-selling Colourstay 24 hour foundation. Colourstay is the number one longwear foundation in America, and for good reason. Not only does it offer a medium to full coverage formula that is totally buildable, but it contains SPF 15 and is formulated with zit-fighting salicylic acid. As an oil free formula, it controls shine and allows for a velvet-matte finish that’s intended to carry you from whatever you’re doing in the day right through your evening activities without the need for reapplication. The foundation comes in an extensive 41 shades, and those who register for the event can pop in and be shade matched before being gifted a full size Colourstay Foundation. If you fancy this or one of the other treatments on offer (see below), then all you need do is check out the Eventbrite page to choose your desired time slot. Treatments will be allocated on a first-come first-served basis so hurry, as this one’s sure to get booked up fast. Once matched, you’ll be able to check out the ColorStay vending machine for a sample of your prescribed shade. There are 41 true-to-skin flawless shades to choose from. Trial the full ColorStay range from the best-selling ColorStay Crème Eyeshadows to its new ColorStay Prep & Protect Primer via the on-hand professional make-up artists. | ||
| add to favorites | This Revlon PhotoReady Candid Concealer Review | Cars |
| This Revlon PhotoReady Candid Concealer Review I admit that as someone who works in beauty, I occassionally get so swept up in the glitz and glamour of luxury brands, I forget how great a good drugstore buy can be for my makeup routine — not to mention, my wallet. In the end, my top priorities when buying face products are that they look awesome on my skin and protect or provide benefits, so that I don't feel guilty wearing them everyday. This Revlon Candid Antioxidant Concealer review is proof that drugstore products can check off all the boxes, as I tried out the brand's entire new PhotoReady Candid Collection, and I'm quite pleased with the results.bb cushion maybelline untuk kulit berminyak While it's true, the packaging is cute, Revlon insists it's the formula inside that makes this new line so good, not to mention so good for you. The PhotoReady Candid Antioxidant Concealer, PhotoReady Candid Natural Finish Anti-Pollution Foundation, and PhotoReady Candid Anti-Pollution Setting Powder are all formulated without oils, parabens, phthalates, synthetic dyes, and fragrances. In place of these, they've jam-packed the products with Vitamin E, an antioxidant that doubles as an anti-pollutant. They've also included pigments and powders that they claim will protect the skin against environmental stressors, as well as prevent blue light from harming your complexion. This collection instantly caught my attention with its perfect combo of cute packaging and healthy skin ingredients, so I decided to take it for a test drive — and ended up discovering my new favorite concealer in the process. When it came time to choose my products, I was decently impressed with the foundation's shade range. With 31 shades, there were an impressive amount of undertone options included, especially for a drugstore base product, and while there are multiple dark and deep dark shades available, there's always room to expand a shade range on both the dark and light ends of the spectrum. On the other hand, the concealer only comes in 18 shades, including one universal shade, "Banana," to neutralize and brighten. Because I love this formula the most, I hope they expand its range to match all 31 foundation tones, or more. The powder comes in just one universal translucent shade, which has a slightly pinky tint to brighten. While the foundation formula is rather thick, I felt it spread out and applied easily and evenly, and found it dried down rather quickly to a natural, semi-matte finish. I didn't feel the need to set my combination skin, and while up close, the pores around my cheeks were a little more visible than I'd like, I did notice my skin overall appeared to have a slightly blurred effect, which I really liked. I'd definitely press a pore-filling primer into certain areas the next time around, but overall, I really liked the natural finish. The coverage was light, but easily buildable to medium, and I found that layering this foundation didn't cause it to get funky or feel heavy at all. It didn't completely mask my acne scars, but I liked how even and bright my skin looked. So far, so good! | ||
| add to favorites | 3 Products Adwoa Aboah’s Makeup Artist Swears By For Her Fresh Skin Look | Cars |
| 3 Products Adwoa Aboah’s Makeup Artist Swears By For Her Fresh Skin Look Model Adwoa Aboah's fresh complexion is often the envy of people everywhere but behind the scenes she often talks about her struggle with skin concerns, such as acne. For high profile shoots (and the odd Instagram selfie) however, her friend and makeup artist Celia Burton is always on hand to ensure she feels comfortable in her skin, but her go-to makeup routine isn't as high maintenance as you might think. Here are the complexion products and clever tricks Celia swears by for achieving Adwoa's signature fresh skin look.bagaimana cara menghilangkan komedo di hidung Adwoa is diligent about her skincare routine, prescribed by a facialist, according to Celia, and so always moisturises prior to sitting in the makeup chair. For that reason, Celia just goes straight for foundation, but there's a knack to application. "Adwoa is really freckly, so a heavy foundation applied all over just looks weird on her," said Celia, who opts for an oil-free base, like Revlon's Colorstay Foundation, £12.99. "We use a 'dot to dot' method and cover up any redness only. If we're looking to hide just one red blemish, then I’ll use concealer, but if the skin is a little more hormonal and patchy, a foundation is best and it should always be slightly sheer." For seamless blending, Celia prefers a Beautyblender, £17, over brushes or using her fingers. "Beautyblenders lighten the load of the foundation and give skin a realistic texture," she said. It also pays to apply foundation in natural light, "especially on darker skin," said Celia. "I use something a little bit pink-toned under Adwoa's eyes and blur it out with the Beautyblender, but it's usually not a really heavy colour corrector," said Celia. "I like Becca's Backlight Targeted Colour Corrector, £24, and use this as an eye brightener. It’s my go-to. If you wanted to, you could simply use a pink highlighter under the eye, but make it a cream." To set whatever makeup I’ve put on the skin, I always use a little bit of translucent powder," said Celia. "Because Adwoa doesn’t wear that much makeup apart from a cream base, I have to set it. Otherwise, you could end up looking really shiny. It’s about taking away the areas you don’t want to reflect much light, such as the nose and forehead. I'd advise leaving the rest of your face totally free from powder because it’s so lovely to see that glow along the top of the cheekbones."Depending on whether Adwoa wants a warmer look, Celia sometimes adds a veil of bronzer. "Unlike foundation, bronzer is the only thing I put all over her face," she told R29. "It just brightens her skin. I tend to focus more on the high points of the face," such as the cheekbones and around the forehead. | ||
| add to favorites | All Hallows’ Eve Has Arrived At Casoo Casino Today | Cars |
| All Hallows’ Eve Has Arrived At Casoo Casino Today Halloween is one of the most famous holidays worldwide. On this day, people carve pumpkins, dress like witches, ghosts and other scary night creatures. However, people did not always carve pumpkins. Some people prefer rather a different way of celebrating the holiday. For example, some of them prefer to increase their revenues from the comfort of their home. The best way to do so is to visit your favourite online casino and make use of its Halloween promotion. Despite the fact that you might find difficulties which brand to choose, we have the best answer to your query. Casoo Casino has launched an All Hallows’ Eve for all players, starting on October 30 and running until November 3. This Halloween, Casoo Casino is very generous with its special promotion on behalf of the holiday. The promotional event at the casino includes a €10,000 Halloween Race and exclusive daily bonuses with free spins on Halloween-themed slots. In addition to this, players will be able to make use of a limited use 100% up to €500 reload bonus and discounts on store items. Pretty amazing, isn’t it? Instead of dancing and singing for treats, online casino players now have the opportunity to bet and win.casino affiliate program The general rules of All Hallows’ Eve are very easy to follow. First of all, you have to be a member of the brand. Following this, you can enrol in the tournament and start spinning in order to climb the leaderboard. Bear in mind that you can play the tournament on some of the best Halloween-themed slots. Fancy of Halloween? How about Halloween combined with some competitive spirit? The more points you win, the higher your position will be in the ranking. Head over to the casino and spin your way for a share of €10000. In terms of the prizes, you can stabilise your financial situation while playing the spookiest games in the industry. Below you can find out what the 3 best performers will win. Even though some people might think that the Halloween Race is enough for the brand to attract the gambling society, Casoo Casino does not share this opinion. In addition to the tournament, players can expect an exclusive daily bonus, too. All players have the potential to win free spins when playing one of the qualifying games. They include Tome of Madness, Ghosts ‘N’ Gold, The Wolf’s Night, Relic Hunters, Halloween Jack & Wolf Hunters. Did you notice your favourite Halloween title? Well, if you did, you can now visit the casino and claim your free spins. If not, you can still give them a go and see whether you will be lucky. All you have to do is to deposit some money and take advantage of your free spins. Last but certainly not least, Casoo Casino is offering an exclusive reload bonus to its players. 100% Halloween special reload bonus which is active during the qualifying period with the advantage to play Yggdrasil and Red Tiger Gaming slots. However, bear in mind that as with every bonus, there are some wagering requirements you have to comply with. The advantage for Red Tiger Gaming and Yggdrasil wagering requirements will be 125%, while it will be 100% for all other games. | ||
| add to favorites | Oaklawn Announces Increase In Employees’ Minimum Wage | Cars |
| Oaklawn Announces Increase In Employees’ Minimum Wage Oaklawn Racing Casino Resort in Hot Springs is raising the minimum wage for its nearly 1,000 employees. The racetrack and casino said Monday that it would increase the minimum wage for non-tipped employees from $9.25 per hour to $13 per hour starting at the end of September. Tipped employees will see their minimum wage increase from $2.76 per hour to $6 per hour.affiliate program Oaklawn says the change affects about 970 full-time, part-time and seasonal employees.Oaklawn is expanding after voters legalized casino gambling in four counties in 2018. Construction is now underway on a $100 million expansion, which includes adding a hotel and event center. In 2018, Arkansas voters approved an initiative to gradually raise the state’s minimum wage to $11 an hour by 2021.NewCasinos.nz is a great place for casino and sports betting related news as well as lots of interesting articles from the gambling world. We publish new posts daily with quality content about sports, games, casino and news. We strive to deliver the most important things happening in gambling on our site, we are up to date on the latest news and what’s happening in casino, sport and gaming to give you the hottest information. You can also find special offers and promotions going on at other casinos to enjoy really nice bonuses. We also share a lot of posts on our Facebook page, where we continuously share information about offers, new casinos and interesting articles. Give it the same to get interesting information from us in your news feed and engage in conversations with other gaming enthusiasts. Add this website among your bookmarks to use this site as a news portal for your interests. If you are already updated on our latest articles, you can browse back in our large archive where we promise you will find very entertaining content. | ||
Please register or log in.
Powered by Noah's Classifieds 3.2.0 -
try Noah's Classifieds V8 e-commerce enabled